GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **426 - 450** of **4050** in total

« First

‹ Prev

…

14

15

16

17

18

19

20

21

22

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgM	Patient 1	10	moderate	G90223GH	63
IgM	Patient 1	22	moderate	G90223GH	192
IgG	Patient 1	6	moderate	G90223GH	25
IgM	Patient 1	6	moderate	G90223GH	52
IgA	Patient 2	15	mild	G90223GH	532
IgA	Patient 2	24	mild	G90223GH	664
IgG	Patient 2	15	mild	G90223GH	184
IgG	Patient 2	24	mild	G90223GH	229
IgM	Patient 2	15	mild	G90223GH	277
IgA	Patient 2	3	mild	G90223GH	688
IgG	Patient 2	3	mild	G90223GH	272
IgM	Patient 2	24	mild	G90223GH	356
IgM	Patient 2	3	mild	G90223GH	413
IgA	Patient 3	-180	mild	G90223GH	283
IgA	Patient 3	11	mild	G90223GH	389
IgG	Patient 3	-180	mild	G90223GH	39
IgM	Patient 3	-180	mild	G90223GH	86
IgA	Patient 3	4	mild	G90223GH	502
IgG	Patient 3	11	mild	G90223GH	45
IgG	Patient 3	4	mild	G90223GH	48
IgM	Patient 3	11	mild	G90223GH	178
IgM	Patient 3	4	mild	G90223GH	214
IgA	Patient 4	12	mild	G90223GH	356
IgG	Patient 4	12	mild	G90223GH	48
IgM	Patient 4	12	mild	G90223GH	125